Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Barchart Impact Releases

Fri, May 16th, 2025
Contributor Content

This article could contain syndicated content. We have not reviewed, approved, or endorsed the content and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here

Wall Street Giants Are Quietly Pouring Billions Into This Overlooked Asset Class—And Now, You Can Too

The little-known strategy institutions are using to protect wealth and earn strong returns—finally available to individual investors.

This AI Startup Is Hacking Human Psychology to Reinvent Digital Ads—And Some of the World’s Largest Billion-Dollar Brands are Seeing Incredible Results

We’re living through the one of the largest shifts in traditional advertising in years . CPMs are skyrocketing, consumer trust is eroding, and most digital campaigns are dead on arrival. But what if...

EXANTE On Insider Trading: A Commitment to Market Integrity and Compliance

EXANTE, a regulated investment firm, adheres to global regulations like MAR to prevent insider trading through strict surveillance, reporting, and compliance, while also educating investors on how to uphold...

CBDCs vs. Stablecoins: What’s the Real Difference and Why It Matters

There are key differences between Central Bank Digital Currencies (CBDCs), which are government-issued digital money, and stablecoins, which are privately issued digital tokens, highlighting their varying...

This Under-The-Radar Cancer Biotech Reports 21% Tumor Shrinkage: Analysts See 600%+ Upside

A clinical-stage biotech company focused on synthetic lethality has reported promising progress across its cancer drug pipeline, highlighted by early signs of tumor reduction in multiple patients, with...

APRE : 1.8000 (+17.65%)
Ride Out Market Volatility: Gainbridge Annuity Offers Guaranteed 5.8% Returns for Up to 10 Years

This is sponsored content. Barchart is not endorsing the websites or products set forth below. Gainbridge, a digital platform transforming access to annuity products , has introduced an incredible option...

Lantern Pharma (LTRN) Gets FDA Clearance for Clinical Trial Targeting Treatment-Resistant, Genomically-Defined Lung Cancer with AI developed LP-184

Lantern Pharma has received FDA clearance to begin a Phase 1b/2 trial of its AI-developed drug LP-184 for treatment-resistant non-small cell lung cancer (NSCLC) with KEAP1/STK11 mutations and

LTRN : 3.86 (-4.93%)
Dr. Zhong Liu: Leading Cutting-Edge Research in AI Sleep Medicine and AI Cardiovascular Dynamics at Harvard Medical School

Dr. Zhong Liu is making significant advancements in AI applications for life sciences and interdisciplinary medical technologies, particularly in AI sleep medicine and cardiovascular dynamics, at Harvard...

Chemomab Leadership Changes Signal Strategic Momentum Following Positive Clinical Results

Following positive Phase 2 trial results for its PSC treatment nebokitug, Chemomab has strategically appointed a new interim CMO and promoted a new CDO to lead the company into its next phase

CMMB : 1.2900 (+6.61%)
Tariff Elimination Sends Shockwaves Through Smart Home Market — One Stock is Perfectly Positioned to Soar

This is sponsored content. Barchart is not endorsing the websites or products set forth below. In a sweeping economic shift, President Trump has officially removed tariffs on consumer electronics —...

Tweets @Barchart

Barchart
@Barchart
There isn't going to be much of us left to sell at this rate Michael 😂😂 https://t.co/gChKiQwVdl
Barchart
@Barchart
Barchart
@Barchart
Oh boy, here we go!! Global 30-Year Bond Yields from Europe to North America to Asia are screaming "EMERGENCY" 🚨🚨 https://t.co/2OGW7GKnqa
Barchart
@Barchart
$1.2 Trillion of S&P 500 $SPX notional options exposure is set to expire on Friday with a max pain price currently sitting at 5,840 🚨🚨 https://t.co/TJlOYEjuXv
Barchart
@Barchart
Barchart
@Barchart
U.S. may reduce capital requirements set up due to the Global Financial Crisis 🚨 Probably Fine? https://t.co/h4g8Li8iY7
Barchart
@Barchart
JUST IN 🚨: Japan's 40-year bond yield just jumped to 3.47%, its highest level in 2 decades 👀 https://t.co/VX9BSoBp6w
Barchart
@Barchart
UnitedHealth $UNH has fallen more than 27% this week, on track for its worst week since August 1998 🚨 https://t.co/W0ly6bDV3K
Barchart
@Barchart
U.S. Homebuilder Confidence falls to lowest level since November 2023 https://t.co/5fy6BDgSWx
Barchart
@Barchart

Chart of the Day

Nutanix Inc (NTNX)

Nutanix (NTNX) shows strong technical momentum and is trading above all its moving averages. NTNX shares set a new 52-week high of $83.14 on Wednesday. The stock has gained 29% in the last month and nearly 18% over the past year. Fundamentals are solid, with revenue and earnings expected to...
Read More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar